Vitestro
1 known investors
Vitestro develops Aletta®, an autonomous blood collection (phlebotomy) device that uses automation and clinical validation to standardize blood draws. It targets hospitals and laboratories seeking to address phlebotomy staffing shortages and reduce preanalytical errors.